GLP-1 agonists should also be avoided by those with a history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2), as these conditions may increase the risk of medullary thyroid carcinoma
Additionally, there's interest in investigating how FOXO4-DRI might work in conjunction with other senolytic agents or treatments to combat age-related diseases more effectively
GLP-1 medications help with that, of course
Here's the science bit: drugs like Ozempic, WeGovy and Mounjaro work as GLP-1 agonists - essentially, they mimic the effects of our natural GLP-1 production, meaning they can help treat obesity and conditions such as diabetes, and insulin sensitivities such as polycystic ovarian syndrome (PCOS)
BHA penetrates inside pores to clear congestion, blackheads, and excess sebum